Opzioni
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma
2022
Periodico
MOLECULAR IMMUNOLOGY
Abstract
Background: The component of the classical pathway C1q
and hyaluronic acid (HA) play a pivotal role in malignant pleural
mesothelioma (MPM) tumour microenvironment and their interaction
has been demonstrated to favour pro-tumorigenic behaviours
of MPM cells by enhancing adhesion, migration and proliferation
(Agostinis et al., 2017), as well as by upregulating the hyaluronan
synthase HAS3 (Vidergar et al., 2021), increasing the production
of short pro-invasive and pro-metastatic HA fragments. Here, we
aimed to determine whether HA-bound C1q can exert its modulation
also on hyaluronidase (HYAL1, HYAL2, HYAL3) expression, the
enzymes responsible for HA degradation, and which receptors may
be involved in this process.
Methods: Real-time qPCR, flow cytometry and Western blot
analysis were performed on primary MPM cells to evaluate HYAL
expression, upon treatment with C1q-HA matrix. Enzyme distribution
was inquired by immunofluorescence, surface biotinylation
assay and proximity ligation assay (PLA). The bioinformatics tool
GEPIA was used for TCGA-based survival analysis.
Results: Real-time qPCR in MPM cells highlighted a downregulation
of HYAL1 and an upregulation of HYAL2 expression, upon
treatment with C1q-HA matrix, as compared to HA alone, then confirmed
at protein level by Western blot and flow cytometry. No
significant modulation was observed on HYAL3. Since only HYAL2
mRNA expression levels found a correlation with MPM patient
survival by bioinformatics analysis, being associated with poorer
outcome, we proceeded with the characterization of HYAL2 distribution
and potential interaction with HA or C1q receptors to better
understand their interplay: we detected a striking overlap between
HYAL2 and globular C1q receptor (gC1qR) localization both at the
cell membrane and intracellularly, by immunofluorescence colabelling,
surface biotinylation assay and PLA. PLA confirmed also
HYAL2-CD44 interaction.Conclusion: C1q-HA interaction can act as a signaling complex
by enhancing HYAL2 expression, suggesting a consequent higher
rate of HA catabolism and the release of shorter HA fragments,
confirming an overall pro-tumorigenic effect promoted by C1q
interaction with HA. The co-localization and interaction between
HYAL2 and gC1qR, being a receptor of both C1q globular head and
HA, led us to hypothesize a potential involvement of gC1qR within
this macromolecular complex, most likely requiring the presence
of the preferential HA receptor CD44.
References
Agostinis, C., Vidergar, R., Belmonte, B., et al., 2017. Complement protein C1q binds to hyaluronic acid in the malignant pleural
mesothelioma microenvironment and promotes tumor growth.
Front. Immunol. 8, 1559, doi: 10.3389/fimmu.2017.01559.
Vidergar, R., Balduit, A., Zacchi, P., et al., 2021. C1q-HA matrix
regulates the local synthesis of hyaluronan in malignant pleural
mesothelioma by modulating HAS3 expression. Cancers (Basel) 13
(3), 416, doi:10.3390/cancers13030416.
Diritti
open access
license:copyright editore
license:creative commons
license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/